QIAGEN Quick Ratio 2006-2020 | QGEN

Historical quick ratio values for QIAGEN (QGEN) over the last 10 years.
QIAGEN Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2020-03-31 $1.41B $1.00B 1.42
2019-12-31 $1.40B $0.95B 1.47
2019-09-30 $1.37B $0.63B 2.18
2019-06-30 $1.45B $0.91B 1.59
2019-03-31 $1.43B $0.94B 1.52
2018-12-31 $1.99B $0.97B 2.05
2018-09-30 $1.71B $1.37B 1.25
2018-06-30 $1.53B $0.94B 1.63
2018-03-31 $1.59B $0.82B 1.94
2017-12-31 $1.49B $0.33B 4.59
2017-09-30 $1.41B $0.30B 4.78
2017-06-30 $1.00B $0.30B 3.34
2017-03-31 $0.62B $0.27B 2.26
2016-12-31 $0.90B $0.31B 2.92
2016-09-30 $0.82B $0.25B 3.27
2016-06-30 $0.76B $0.25B 3.06
2016-03-31 $0.81B $0.25B 3.31
2015-12-31 $0.83B $0.27B 3.07
2015-09-30 $0.84B $0.28B 3.04
2015-06-30 $0.79B $0.27B 2.98
2015-03-31 $0.82B $0.33B 2.47
2014-12-31 $1.02B $0.43B 2.36
2014-09-30 $1.14B $0.44B 2.61
2014-06-30 $1.07B $0.30B 3.60
2014-03-31 $1.08B $0.31B 3.45
2013-12-31 $0.79B $0.34B 2.35
2013-09-30 $0.73B $0.30B 2.41
2013-06-30 $0.77B $0.30B 2.59
2013-03-31 $0.85B $0.27B 3.17
2012-12-31 $0.86B $0.27B 3.21
2012-09-30 $0.66B $0.54B 1.22
2012-06-30 $0.60B $0.51B 1.18
2012-03-31 $0.63B $0.45B 1.38
2011-12-31 $0.61B $0.45B 1.36
2011-09-30 $0.83B $0.65B 1.28
2011-06-30 $1.27B $0.37B 3.47
2011-03-31 $1.26B $0.38B 3.35
2010-12-31 $1.24B $0.39B 3.19
2010-09-30 $1.22B $0.40B 3.09
2010-06-30 $1.24B $0.32B 3.84
2010-03-31 $1.21B $0.34B 3.57
2009-12-31 $1.20B $0.38B 3.20
2009-09-30 $1.24B $0.38B 3.29
2009-06-30 $0.67B $0.26B 2.52
2009-03-31 $0.60B $0.22B 2.68
2008-12-31 $0.60B $0.26B 2.27
2008-09-30 $0.59B $0.22B 2.77
2008-06-30 $0.63B $0.18B 3.43
2008-03-31 $0.60B $0.17B 3.52
2007-12-31 $0.56B $0.17B 3.38
2007-09-30 $0.53B $0.19B 2.85
2007-06-30 $0.64B $0.13B 5.01
2007-03-31 $0.64B $0.13B 4.83
2006-12-31 $0.62B $0.12B 5.31
2006-09-30 $0.63B $0.11B 5.62
2006-06-30 $0.00B 0.00
2006-03-31 $0.00B 0.00
2005-12-31 $0.32B $0.09B 3.45
2005-09-30 $0.31B $0.08B 4.07
2005-06-30 $0.31B $0.09B 3.49
2005-03-31 $0.34B $0.07B 4.56
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.727B $1.526B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $150.074B 16.52
Gilead Sciences (GILD) United States $95.408B 12.37
CSL (CSLLY) Australia $89.956B 0.00
Vertex Pharmaceuticals (VRTX) United States $74.226B 51.03
Regeneron Pharmaceuticals (REGN) United States $67.020B 25.83
Illumina (ILMN) United States $54.177B 55.67
Biogen (BIIB) United States $43.207B 7.40
Seattle Genetics (SGEN) United States $28.998B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.819B 10.66
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
Moderna (MRNA) United States $22.864B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.757B 206.29
Incyte (INCY) United States $22.313B 0.00
Genmab (GMAB) Denmark $21.588B 17.78
Genmab (GNMSF) Denmark $20.261B 60.15
Alnylam Pharmaceuticals (ALNY) United States $17.162B 0.00
BeiGene (BGNE) Cayman Islands $14.631B 0.00
BioNTech SE (BNTX) Germany $14.512B 0.00
Galapagos (GLPG) Belgium $13.209B 38.86
Exact Sciences (EXAS) United States $13.106B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Sarepta Therapeutics (SRPT) United States $12.921B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.711B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.537B 25.93
Bio-Techne Corp (TECH) United States $10.168B 67.17
Immunomedics (IMMU) United States $8.523B 0.00
Guardant Health (GH) United States $7.919B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.838B 0.00
Ascendis Pharma (ASND) Denmark $7.335B 0.00
Exelixis (EXEL) United States $7.206B 25.27
Repligen (RGEN) United States $6.496B 113.94
Adaptive Biotechnologies (ADPT) United States $6.063B 0.00
Acceleron Pharma (XLRN) United States $5.182B 0.00
Mirati Therapeutics (MRTX) United States $5.131B 0.00
Reata Pharmaceuticals (RETA) United States $5.116B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.050B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.864B 104.67
Vir Biotechnology (VIR) United States $4.669B 0.00
Zai Lab (ZLAB) China $4.631B 0.00
Novavax (NVAX) United States $4.619B 0.00
MyoKardia (MYOK) United States $4.381B 0.00
Emergent Biosolutions (EBS) United States $4.294B 28.15
Global Blood Therapeutics (GBT) United States $4.293B 0.00
Blueprint Medicines (BPMC) United States $4.282B 0.00
MorphoSys AG (MOR) Germany $4.260B 33.04
China Biologic Products (CBPO) China $4.014B 22.32
Amicus Therapeutics (FOLD) United States $4.007B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.742B 0.00
Halozyme Therapeutics (HALO) United States $3.721B 0.00
NeoGenomics (NEO) United States $3.503B 255.85
Bluebird Bio (BLUE) United States $3.396B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.249B 0.00
Arena Pharmaceuticals (ARNA) United States $3.145B 0.00
Alkermes (ALKS) Ireland $3.137B 61.75
Inovio Pharmaceuticals (INO) United States $3.119B 0.00
Insmed (INSM) United States $2.950B 0.00
Fate Therapeutics (FATE) United States $2.808B 0.00
Amarin (AMRN) Ireland $2.710B 0.00
Denali Therapeutics (DNLI) United States $2.666B 0.00
Viela Bio (VIE) United States $2.114B 0.00
UniQure (QURE) Netherlands $2.048B 0.00
PHARMA MAR SA (PHMMF) Spain $2.014B 0.00
Alector (ALEC) United States $1.973B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.968B 0.00
Principia Biopharma (PRNB) United States $1.929B 0.00
Twist Bioscience (TWST) United States $1.863B 0.00
Eidos Therapeutics (EIDX) United States $1.851B 0.00
Ligand Pharmaceuticals (LGND) United States $1.796B 69.94
Editas Medicine (EDIT) United States $1.704B 0.00
Adverum Biotechnologies (ADVM) United States $1.693B 0.00
I-Mab (IMAB) China $1.689B 0.00
Intra-Cellular Therapies (ITCI) United States $1.674B 0.00
Zymeworks (ZYME) Canada $1.656B 0.00
Epizyme (EPZM) United States $1.598B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.533B 0.00
Mersana Therapeutics (MRSN) United States $1.517B 0.00
Beam Therapeutics (BEAM) United States $1.468B 0.00
Sorrento Therapeutics (SRNE) United States $1.453B 0.00
REGENXBIO (RGNX) United States $1.443B 0.00
Revance Therapeutics (RVNC) United States $1.434B 0.00
Akcea Therapeutics (AKCA) United States $1.405B 0.00
Cytokineticsorporated (CYTK) United States $1.404B 0.00
Zealand Pharma (ZEAL) Denmark $1.381B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
Mesoblast (MESO) Australia $1.349B 0.00
Arvinas (ARVN) United States $1.337B 0.00
Sangamo Therapeutics (SGMO) United States $1.321B 0.00
NGM Biopharmaceuticals (NGM) United States $1.319B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.300B 0.00
Coherus BioSciences (CHRS) United States $1.294B 9.03
NantKwest (NK) United States $1.156B 0.00
Intellia Therapeutics (NTLA) United States $1.130B 0.00
Athenex (ATNX) United States $1.130B 0.00
Arcus Biosciences (RCUS) United States $1.077B 0.00
Compugen (CGEN) Israel $1.009B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.970B 0.00
Alcobra (ARCT) United States $0.960B 0.00
Retrophin (RTRX) United States $0.893B 0.00
Heska (HSKA) United States $0.872B 0.00
Myriad Genetics (MYGN) United States $0.839B 43.27
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.828B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
Intrexon (PGEN) United States $0.818B 0.00
Morphic Holding (MORF) United States $0.798B 0.00
Kadmon Holdings (KDMN) United States $0.770B 0.00
Cellectis S.A (CLLS) France $0.767B 0.00
Dynavax Technologies (DVAX) United States $0.766B 0.00
Bellus Health (BLU) Canada $0.714B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.707B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.701B 0.00
Frequency Therapeutics (FREQ) United States $0.700B 0.00
Codexis (CDXS) United States $0.689B 0.00
VBI Vaccines (VBIV) United States $0.678B 0.00
Castle Biosciences (CSTL) United States $0.674B 0.00
Agenus (AGEN) United States $0.673B 0.00
Vericel (VCEL) United States $0.671B 123.92
Aquinox Pharmaceuticals (NLTX) United States $0.653B 0.00
Cue Biopharma (CUE) United States $0.652B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.651B 5.57
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
AnaptysBio (ANAB) United States $0.629B 0.00
MiMedx (MDXG) United States $0.597B 0.00
Kala Pharmaceuticals (KALA) United States $0.581B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.576B 0.00
NextCure (NXTC) United States $0.571B 0.00
Anika Therapeutics (ANIK) United States $0.548B 17.61
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Cel-Sci (CVM) United States $0.540B 0.00
Athersys (ATHX) United States $0.534B 0.00
Prometic Life Sciences (LMNL) Canada $0.534B 0.00
UROGEN PHARMA (URGN) United States $0.533B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.525B 0.00
Syros Pharmaceuticals (SYRS) United States $0.522B 0.00
Scholar Rock Holding (SRRK) United States $0.521B 0.00
Clovis Oncology (CLVS) United States $0.514B 0.00
DBV Technologies S.A (DBVT) France $0.493B 0.00
Protagonist Therapeutics (PTGX) United States $0.480B 0.00
Merus (MRUS) Netherlands $0.465B 0.00
AC Immune SA (ACIU) Switzerland $0.463B 0.00
MeiraGTx Holdings (MGTX) United States $0.455B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.453B 0.00
Geron (GERN) United States $0.437B 0.00
Precision BioSciences (DTIL) United States $0.435B 0.00
BioDelivery Sciences (BDSI) United States $0.434B 22.79
Prothena (PRTA) Ireland $0.421B 0.00
Puma Biotechnology (PBYI) United States $0.419B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.416B 0.00
Avid Bioservices (CDMO) United States $0.403B 0.00
WAVE Life Sciences (WVE) Singapore $0.393B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
Kamada (KMDA) Israel $0.392B 16.32
CytomX Therapeutics (CTMX) United States $0.391B 0.00
ANI Pharmaceuticals (ANIP) United States $0.386B 7.65
Affimed (AFMD) Germany $0.361B 0.00
MannKind (MNKD) United States $0.360B 0.00
Seres Therapeutics (MCRB) United States $0.348B 0.00
PDL BioPharma (PDLI) United States $0.347B 298.00
OSMOTICA PHARM (OSMT) United States $0.344B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Starpharma Holdings (SPHRY) Australia $0.303B 0.00
Celldex Therapeutics (CLDX) United States $0.302B 0.00
Menlo Therapeutics (MNLO) United States $0.290B 0.00
Pfenex (PFNX) United States $0.283B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.283B 0.00
ChromaDex (CDXC) United States $0.278B 0.00
Verastem (VSTM) United States $0.273B 0.00
Spero Therapeutics (SPRO) United States $0.273B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.271B 0.00
IVERIC Bio (ISEE) United States $0.265B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.257B 0.00
Selecta Biosciences (SELB) United States $0.248B 0.00
IBio (IBIO) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.246B 0.00
HOOKIPA Pharma (HOOK) United States $0.245B 0.00
Gritstone Oncology (GRTS) United States $0.244B 0.00
Dyadic (DYAI) United States $0.242B 0.00
Northwest Biotherapeutics (NWBO) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
Liquidia Technologies (LQDA) United States $0.235B 0.00
Five Prime Therapeutics (FPRX) United States $0.235B 0.00
Aptinyx (APTX) United States $0.226B 0.00
Fortress Biotech (FBIO) United States $0.224B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.220B 0.00
Pluristem Therapeutics (PSTI) Israel $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.215B 3.24
XOMA (XOMA) United States $0.212B 0.00
Strongbridge Biopharma (SBBP) United States $0.209B 0.00
Exicure (XCUR) United States $0.209B 0.00
GENFIT S.A (GNFT) France $0.209B 0.00
POXEL SA FRANCE (PXXLF) France $0.202B 0.00
Aduro Biotech (ADRO) United States $0.202B 0.00
ARAVIVE, INC (ARAV) United States $0.183B 0.00
Sutro Biopharma (STRO) United States $0.180B 0.00
Kindred Biosciences (KIN) United States $0.178B 0.00
Aytu Bioscience (AYTU) United States $0.170B 0.00
Trevena (TRVN) United States $0.169B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.163B 0.00
Cyclerion Therapeutics (CYCN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.159B 0.00
VTv Therapeutics (VTVT) United States $0.155B 0.00
Cerecor (CERC) United States $0.153B 0.00
Theratechnologies (THTX) Canada $0.151B 0.00
Cidara Therapeutics (CDTX) United States $0.150B 0.00
Applied Genetic Technologies (AGTC) United States $0.150B 0.00
VolitionRX (VNRX) United States $0.149B 0.00
Biofrontera AG (BFRA) Germany $0.148B 0.00
Celyad SA (CYAD) Belgium $0.147B 0.00
TELA Bio (TELA) United States $0.142B 0.00
Lumos Pharma (LUMO) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.131B 0.00
Orgenesis (ORGS) United States $0.127B 0.00
Arbutus Biopharma (ABUS) United States $0.126B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.124B 0.00
Protalix BioTherapeutics (PLX) Israel $0.122B 0.00
Eton Pharmaceuticals (ETON) United States $0.120B 0.00
Oncobiologics (OTLK) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
AIT Therapeutics (XAIR) United States $0.115B 0.00
Palatin Technologies (PTN) United States $0.114B 2.93
Celsion (CLSN) United States $0.111B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
AquaBounty Technologies (AQB) United States $0.100B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
Windtree Therapeutics (WINT) United States $0.095B 0.00
Cardiff Oncology (CRDF) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Clearside Biomedical (CLSD) United States $0.090B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
Cocrystal Pharma (COCP) United States $0.077B 0.00
Organovo Holdings (ONVO) United States $0.073B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
Synlogic (SYBX) United States $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.064B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Signal Genetics (MGEN) United States $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Vaccinex (VCNX) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Soligenix (SNGX) United States $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Bionano Genomics (BNGO) United States $0.048B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Curis (CRIS) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Spherix (AIKI) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
MYOS RENS Technology (MYOS) United States $0.027B 0.00
IMMURON (IMRN) Australia $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Novogen (KZIA) Australia $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
AEterna Zentaris (AEZS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00